Qualigen Therapeutics Inc (QLGN) — Cash Flow Reinvestment Rate
Qualigen Therapeutics Inc (QLGN) has a Cash Flow Reinvestment Rate of 4.81x as of September 2023, reinvesting $4.47 Million (capex $246.42K plus investments $4.23 Million) from operating cash flow of $929.74K. See how much free cash does Qualigen Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qualigen Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Qualigen Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see QLGN cash flow metrics.
Annual Cash Flow Reinvestment Rate for Qualigen Therapeutics Inc (2019–2019)
Year-by-year capital reinvestment analysis for Qualigen Therapeutics Inc. See Qualigen Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 6.78x | $388.95K | $57.33K | $194.48K | — |